In certain genetic human cystic kidney diseases, such as autosomal dominant PKD (ADPKD) associated with PKD1 or PKD2 mutations, in vivo kidney cystogenesis is largely driven by cAMP signaling (Richards et al., 2021). The gene discussed is PKD2; the disease is cystic kidney disease.